MA16.06 Durvalumab ± Tremelimumab + Platinum-Etoposide in 1L ES-SCLC: Exploratory Analysis of HLA Genotype and Survival in CASPIAN
Marina Chiara Garassino, Yashaswi Shrestha, Mingchao Xie, Zhongwu Lai, Stuart Spencer, Tapashi Dalvi, Luis Paz‐Ares
Topics & Concepts
DurvalumabTremelimumabMedicineInternal medicineEtoposideOncologyCarboplatinCisplatinGastroenterologyNivolumabImmunotherapyChemotherapyCancerIpilimumabLung Cancer Research StudiesPeptidase Inhibition and AnalysisCancer therapeutics and mechanisms